REQUEST A DEMO
Total
USD $0.00
Search more companies

Drosan Limitada (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Drosan Limitada Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Drosan Limitada is an enterprise based in Colombia. Its main office is in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on June 19, 1992. It currently has a total number of 85 (2024) employees. There was a net sales revenue increase of 1.73% reported in Drosan Limitada’s latest financial highlights for 2023. Its’ total assets recorded a growth of 11.04%. The net profit margin of Drosan Limitada increased by 1.28% in 2023.

Headquarters
Carrera 25 # 36 - 47 Barrio Bolivar
Bucaramanga; Santander;

Contact Details: Purchase the Drosan Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Drosan Limitada report to view the information.
Outstanding Shares:
Purchase the Drosan Limitada report to view the information.
Registered Capital:
Purchase the Drosan Limitada report to view the information.
Incorporation Date:
June 19, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Drosan Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1.73%
Total operating revenue
1.73%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
35.68%
Total assets
11.04%
Total equity
13.14%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.28%
Return on Equity (ROE)
1.93%
Quick Ratio
0.14%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?